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Abstract
Background: Exposure to arsenic in drinking water has been associated with various complications of pregnancy
including fetal loss, low birth weight, anemia, gestational diabetes and spontaneous abortion. However, to date,
there are no studies evaluating its possible association with preeclampsia.
Methods: This case–control study involved 104 preeclamptic and 202 healthy pregnant women. The concentrations of
arsenic in drinking water and urine were measured using a Microwave Plasma-Atomic Emission Spectrometer.
Results: We found relatively low levels of arsenic in household tap water (range of 2.48–76.02 μg/L) and in the urine of
the participants (7.1 μg/L vs 6.78 μg/L in cases and controls, respectively).
Conclusions: The analysis between groups showed for the first time that at these lower levels of exposure there is no
association with preeclampsia.
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Background
Preeclampsia (PE) is a disorder peculiar to pregnancy
and a major cause of maternal death and adverse fetal
outcome [1]. In developing countries where access to
health care is limited, PE is a leading cause of maternal
mortality, with estimates of more than 60,000 maternal
deaths per year [2] Although the exact pathophysiologic
mechanisms of PE remain elusive, studies to date have
implicated multiple processes, including the following:
abnormal trophoblastic invasion, vasospasm, platelet ac-
tivation, imbalance in the vasomotor-regulating factors
and placental ischemia [3]. PE is characterized by in-
creased oxidative stress due to the imbalance between
lipid peroxidation and antioxidant defense mechanisms,
leading to endothelial dysfunction and free radical medi-
ated cell injury [4].
Arsenic-contaminated drinking water represents a
major public health problem internationally [5–8].
The World Health Organization (WHO) and U.S.
Environmental Protection Agency (EPA) standard for ar-
senic level in drinking water is 10 μg/L [9, 10]. Arsenic
(As) is an established carcinogen and is also associated
with a wide range of other chronic illnesses, such as
diabetes, hypertension, and vascular diseases [11].
Oxidative stress has been identified as an important
mechanism of As toxicity and carcinogenicity. In par-
ticular, As induces oxidative DNA damage and lipid per-
oxidation [12–16]. Oxidative stress and disrupted
antioxidant systems have been shown to be involved in a
wide range of pregnancy complications such as impaired
fetal growth, PE, and miscarriage [17, 18].
Besides the generation of oxidative stress as a possible
mechanism by which As may be associated with PE,
Shin Le et al. reported that exposure to environmentally
relevant concentrations of As (2.5 μM of AsNaO2) in-
hibit the migration of EVT cells (a human extravillous
trophoblast cell line) in vitro, therefore, a similar mech-
anism may be occurring in vivo [19].
Several studies have been conducted to determine the
association between chronic As exposure and adverse
pregnancy outcome. Excess spontaneous abortion,
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stillbirth, and preterm birth rates among women with
chronic As exposure have been reported [20–23]. How-
ever, to date there are no reports that show an associ-
ation between As exposure and PE. This study evaluates
whether As exposure from drinking water is associated
with PE in a population of northern Mexico.
Methods
Patient recruitment
This prospective case–control study was approved by
the Research Ethics Committee of the General Hospital
of the Ministry of Health of Durango, Mexico in accord-
ance with the Code of Ethics of the Declaration of
Helsinki. Signed informed consent was obtained from
all patients and controls before participation in the
study. The sample size was calculated using the for-
mula n = (Zα/2 + Zβ)
2 ṗ (1–ṗ) (r + 1)/d2r. The n needed
to achieve 80 % power with an alpha of 0.05 was 94
(cases) and 188 (controls). Finally, we recruited 104
women diagnosed with PE (cases) and 202 healthy preg-
nant women (controls). The inclusion criteria were all
those women diagnosed with mild PE (blood pressure
(BP) ≥ 140/90 mmHg and proteinuria ≥ 30 mg/dL), severe
PE (BP ≥ 160/110 mmHg and proteinuria ≥ 2000 mg/dL)
and eclampsia (defined as occurrence, in a woman with
PE, of seizures that cannot be attributed to other causes).
The control group was conformed by healthy pregnant
women attending the same hospital; without hypertensive,
pathological or metabolic disorders during pregnancy. Fol-
low up was given to the control group to corroborate the
normality of the blood pressure values.
Sample collection
Within 1–3 weeks of delivery, a drinking water sample
was collected at the homes of each of the study partici-
pants. Drinking-water samples were collected based on
the subject’s primary drinking water source. Maternal
spot urine samples were collected at the hospital before
delivery and immediately transported to the laboratory.
Samples were stored at −80 °C until processing.
Detection of As in drinking water and urine
The concentrations of As in drinking water (DW) and
urine were measured in the toxicology laboratory of
Scientific Research Institute of the Universidad Juárez
del Estado de Durango (UJED) using a Microwave
Plasma-Atomic Emission Spectrometer (MP-AES 4100).
The Trace Elements in Water standard reference mater-
ial (SRM 1643e) (National Institute of Standards and
Technology, Gaithersburg, MD) was used for quality
control. The limit of detection for As in DW by MP-AES
was 0.5 μg As/L. For urine analysis, six point calibration
curves were prepared. To compensate for variation in the
dilution of the urine (caused by variation in fluid intake,
time of sampling, temperature, and physical activity), we
adjusted the concentrations by specific gravity.
Statistical analysis
Independent sample Student’s t-tests were performed
using SPSS software (version 15.0; SPSS Inc., Chicago, IL,
USA). Odds ratios (ORs) as estimates of relative risk of
the disease were calculated with 95 % confidence intervals
(95 % CIs). The ORs were adjusted for variations in age
and weeks of pregnancy by means of a multivariate logistic
regression model. Mann–Whitney U test was used when
the data were not normally distributed. For analysis, our
patients were stratified into 3 groups based on As levels in
DW (Table 3). The Group 1 (G1) presented levels lower
than 10 μg/L, group 2 (G2) levels between 10.1 μg/L and
25 μg/L and group 3 (G3) levels above 25.1 μg/L
Results
Clinical characteristics for controls and cases are shown
in Table 1. Of the 104 women diagnosed with PE, 13
had mild PE, 72 severe PE and 19 eclampsia. Variables
that showed a difference between groups were family
history of PE, systolic and diastolic blood pressure
(mm Hg), weeks of pregnancy and body mass index
(Table 1). The range of As concentration in house-
hold tap water was 2.48–76.02 μg/L with more than
95 % of the participants having As levels higher than
10 μg/L. The mean concentration of As in DW was
39.58 μg/L and 40.49 μg/L for cases and controls, respect-
ively; there were no statistically significant differences
(Table 2, p = 0.816). While the WHO sets a maximum
concentration of 10 μg/L in DW, the authorities in
Mexico have set a maximum concentration of 25 μg/L
(NOM-127-SSA1-1994) [24]. For this reason, the OR was
estimated stratifying our patients into 3 groups based on
As levels in DW. The results of Table 3 show that al-
though the group exposed to concentrations above
25 μg/L presents an increased risk (OR = 1,715). This
difference is not statistically significant (p = 0.214).
Table 1 Clinical characteristics for cases and controls
Clinical features Controls (n = 202) Cases (n = 104) P-value
Age (years) 24.30 (7.078)a 24.39 (7.349)a .92b
Weeks of pregnancy 37.49 (3.96)a 35.82 (3.97)a 0.001b
Systolic BP (mm Hg) 111.74 (10.82)a 158.36 (16.41)a <0.0001b
Diastolic BP (mm Hg) 70.39 (9.97)a 101.21 (10.3)a <0.0001b
Number of pregnancies 2.26 (1.40)a 2.34 (2.49)a 0.718b
Body mass index 24.61 (5.22)a 27.63 (5.82)a <0.0001b
PE antecedent 13/202 14/104 0.045c
aMean ± Standard deviation
bIndependent sample T test
cChi square test
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Total urinary As concentration (U-tAs) was also evalu-
ated. The mean concentration of U-tAs was 7.1 μg/L
and 6.78 μg/L for cases and controls, respectively; there
were no statistically significant differences (Table 2,
p = 0.428). With the intention to establish whether
As may be associated with the severity of PE, the cases
were stratified in mild PE and severe PE/eclampsia. The
results of Table 2 show that there is no statistically signifi-
cant differences in the U-tAs (p =0.788). The risk of PE by
U-tAs was estimated piling up to the patients in tertiles.
The results in Table 3 show that at these levels, U-tAs is
not a risk for PE.
Finally, we evaluated the correlation between As in DW
and U-tAs. We observed an increase in the U-tAs associ-
ated with higher levels of As in DW. G1 presented a mean
of 3.39 μg/L, G2 of 6.67 μg/L and G3 of 7.8 μg/L. How-
ever, the correlation coefficient was very low (R2 = 0.036).
Discussion
To our knowledge this is the first study that evaluates if
As exposure from DW is associated with PE. The As
concentrations in household tap water (2.48–76.02 μg/L)
were consistent with those previously found by our
working group in the wells that provide DW to the city
of Durango [25, 26]. Although these concentrations are
not as high as those reported in other countries [27–30]
or even in other regions of our own locality [31], there is
a tremendous interest in the evaluation of regions with
low or moderate As exposure in accordance with the in-
creasingly clear evidence that relatively low levels of As
can have health effects. Our comparative analysis be-
tween controls and cases evidenced no statistically sig-
nificant differences. In addition, no differences were
found in the analysis based on the severity of the PE.
The analysis of U-tAs showed a mean of 7.1 μg/L for
cases and 6.78 μg/L for controls. These U-tAs levels are
clearly lower than those reported among pregnant
women in Bangladesh (80 μg/L) [32] and even lower
than those reported in pregnant women in the nearby
region known as Comarca Lagunera (23.3 μg/L) [33]. In
our study we didn’t find an association between U-tAs
and PE or an association with the severity of PE. Re-
cently, Joy-Mendez et al. found no association between
serum As levels and blood pressure in a cohort of preg-
nant women from Mexico city [34]. They reported a
mean of 15.2 μg/L of As in serum. Although they don’t
evaluate PE, our results can be considered similar.
In contrast to our results, several reports have asso-
ciated As exposure with pregnancy complications in-
cluding low weight of the newborn [35], fetal death
[36], gestational diabetes [32], anemia [37] and spon-
taneous abortions [38], however, these associations
appear at significantly higher levels of As (e. g., fetal
death, U-tAs >200 μg/L or spontaneous abortions, As
in DW >100 μg/L).
Our results could be interpreted on the one hand, as a
confirmation of no association between As and PE, at
least at these low levels. On the other hand, they might
suggest that we need higher levels of As exposure to be
able to observe the association.
Our study has some limitations. Although the partici-
pants state that their main source of water is from the
tap, we can’t rule out that As can come from other
sources of drinking water (e.g., bottled water), some






Water 40.49 (16.40)a 39.58 (26.43)a 0.816b






Water 46.03 (20.65)a 38.62 (26.87)a 0.519b
Urine 7.82 (6.87)a 7.03 (5.67)a 0.788c
a Mean ± Standard deviation
b Independent sample T test
c Mann–Whitney U test
Table 3 Odds ratio estimation by ranges of arsenic in water and urine













1.715 (0.732–4.019) 0.214 Tertile 3f
n = 102
0.788 (0.411–1.512) 0.214
a DW As < 10 μg/L
b DW As 10.1–25 μg/L
c DW As >25 μg/L
d U-tAs ≤7.4956 μg/L
e U-tAs >7.4956 ≤ 11.4911 μg/L
f U-tAs >11.4911 μg/L
* ORs were adjusted for age and weeks of pregnancy
Sandoval-Carrillo et al. BMC Pregnancy and Childbirth  (2016) 16:153 Page 3 of 5
food, or by some occupational exposure. Another limita-
tion is that we didn’t find high levels of U-tAs, so we
can’t establish in our study if higher levels of urinary As
are or are not associated with PE.
The evaluation of pregnant women with higher levels
of As as well as the analysis of other factors (e.g., genetic
or nutritional) becomes necessary to confirm and
strengthen our findings.
Conclusions
First, it is shown that the majority of our population is
exposed to As levels higher than that established by the
WHO. In addition, our work suggests for the first time
that there is no association between As exposure and
PE.
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